Abstract
SUMMARY: Advances in nanotechnology have the potential to dramatically enhance the detection of neurologic diseases with targeted contrast agents and to facilitate the delivery of focused therapies to the central nervous system. We present the physicochemical rationale for their use, applications in animal models, and ongoing clinical trials using these approaches. We highlight advances in the use of nanoparticles applied to brain tumor imaging, tumor angiogenesis, neurodegeneration, grafted stem cells, and neuroprogenitor cells.
ABBREVIATIONS:
- amyloid beta
- Aβ
- NO
- nitric oxide
- NOS
- nitric oxide synthase
- PBCA
- poly(n-butyl cyanoacrylate)
- QDots
- quantum dots
- SPIO
- superparamagnetic iron oxide
- © 2014 by American Journal of Neuroradiology
Indicates open access to non-subscribers at www.ajnr.org